14.08.2012 Views

Labelling Review row-Online

Labelling Review row-Online

Labelling Review row-Online

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Origin<br />

CD79a<br />

Clone 11E3<br />

50 Tests ORG-8975 IVD<br />

CD79a is a cytoplasmic domain, disulfide linked heterodimer protein. This<br />

protein is noncovalently associated with the membrane bound<br />

immunoglobulins on B cells. This complex of polypeptides and<br />

immunoglobulin constitutes the B cell receptor. The two components of this<br />

complex are designated CD79a and CD79b. The CD79a antigen is reported to<br />

first appear at the pre-B cell stage where it is found as an intracellular<br />

component. The CD79a antigen is reported in the majority of acute<br />

leukemias of precursor B cell types, B cell lines, B cell lymphomas and in<br />

some myelomas. It is not present in myeloid or T cell lines.<br />

Product Specific Information<br />

An antibody panel including Origin CD79a (Clone 11E3) may be used in the<br />

characterization of B cell disorders.<br />

Refer to page 84 for further information about Clone 11E3.<br />

Origin CD79a (Clone 11E3) on tonsil. Paraffin section.<br />

Cytokeratin<br />

Clone 34�E12<br />

50 Tests ORG-8735 IVD<br />

The expression of different cytokeratins in epithelial-derived tumors and the<br />

general tendency towards maintenance of cytokeratin polypeptide patterns<br />

during malignant g<strong>row</strong>th and metastasis serves as a basis for approaching<br />

the characterization of tumors, using cytokeratins as differentiation markers.<br />

Product Specific Information<br />

Origin Cytokeratin (Clone 34�E12) is recommended for the characterization of<br />

squamous and ductal carcinomas arising from complex epithelia and is of<br />

value in the differentiation of benign and malignant small-acinar lesions of the<br />

prostate gland.<br />

Refer to page 137 for further information about Clone 34�E12.<br />

Origin Cytokeratin (Clone 34�E12) on squamous cell carcinoma. Paraffin section.<br />

/ 194<br />

For detailed information on all products please visit our website:<br />

www.leica-microsystems.com<br />

Desmin<br />

Clone DE-R-11<br />

50 Tests ORG-8889 IVD<br />

Human desmin is a 53 kD cytoplasmic intermediate filament protein in<br />

striated and smooth muscle cells. It is confined to the Z bands in skeletal<br />

and cardiac muscle giving a characteristic striated appearance when<br />

immunohistochemically stained.<br />

Product Specific Information<br />

Origin Desmin (Clone DE-R-11) is recommended as an aid in the determination<br />

of tumors of myogenic origin, such as those arising from smooth muscle,<br />

leiomyomas and those derived from striated muscle. The antibody does not<br />

recognize other intermediate filament proteins.<br />

Refer to page 101 for further information about Clone DE-R-11.<br />

Origin Desmin (Clone DE-R-11) on bowel. Paraffin section.<br />

Estrogen Receptor<br />

Clone 6F11<br />

50 Tests ORG-8871 IVD<br />

Estrogen receptor (ER) expression in breast cancer tissue is an important<br />

parameter in the prediction and response to endocrine therapy. Monoclonal<br />

antibodies to ER have allowed the determination of ER status to be carried<br />

out in routine histopathology laboratories quantitatively and qualitatively.<br />

Product Specific Information<br />

Origin Estrogen Receptor (Clone 6F11) is indicated as an aid in prognosis and<br />

prediction of therapy in breast cancer, it binds specifically to the ER alpha<br />

antigen in the nuclei of normal and neoplastic tissues.<br />

Refer to page 106 for further information about Clone 6F11.<br />

Origin Estrogen Receptor (Clone 6F11) on breast carcinoma. Paraffin section.<br />

Products in this catalog are subject to regulatory approval.<br />

This catalog is not for use in the USA.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!